AIM
abrdn Investment Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $403M | Sell |
14,537,918
-4,305,890
| -23% | -$119M | 1.36% | 20 |
|
|
2017
Q1 | $469M | Sell |
18,843,808
-904,489
| -5% | -$22.5M | 1.55% | 16 |
|
|
2016
Q4 | $427M | Buy |
19,748,297
+257,738
| +1% | +$5.58M | 1.49% | 16 |
|
|
2016
Q3 | $464M | Sell |
19,490,559
-195,788
| -1% | -$4.66M | 1.91% | 8 |
|
|
2016
Q2 | $460M | Sell |
19,686,347
-286,634
| -1% | -$6.7M | 2.08% | 8 |
|
|
2016
Q1 | $376M | Sell |
19,972,981
-108,159
| -0.5% | -$2.04M | 1.71% | 15 |
|
|
2015
Q4 | $370M | Buy |
20,081,140
+902,531
| +5% | +$16.6M | 1.57% | 21 |
|
|
2015
Q3 | $315M | Sell |
19,178,609
-9,687
| -0.1% | -$159K | 1.35% | 27 |
|
|
2015
Q2 | $340M | Buy |
19,188,296
+10,724,080
| +127% | +$190M | 1.44% | 24 |
|
|
2015
Q1 | $150M | Buy |
8,464,216
+4,805,367
| +131% | +$85.3M | 0.61% | 61 |
|
|
2014
Q4 | $48.5M | Buy |
3,658,849
+855,241
| +31% | +$11.3M | 0.19% | 98 |
|
|
2014
Q3 | $33.1M | Buy |
2,803,608
+682,639
| +32% | +$8.07M | 0.13% | 128 |
|
|
2014
Q2 | $27.1M | Buy |
2,120,969
+2,062,408
| +3,522% | +$26.3M | 0.12% | 129 |
|
|
2014
Q1 | $792K | Sell |
58,561
-107
| -0.2% | -$1.45K | ﹤0.01% | 290 |
|
|
2013
Q4 | $705K | Buy |
58,668
+1,110
| +2% | +$13.3K | ﹤0.01% | 328 |
|
|
2013
Q3 | $676K | Sell |
57,558
-898
| -2% | -$10.5K | ﹤0.01% | 323 |
|
|
2013
Q2 | $542K | Buy |
+58,456
| New | +$542K | ﹤0.01% | 338 |
|